Business
Trials of AstraZeneca COVID vaccine resuming after ‘wake up call’ – Sydney Morning Herald
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
AstraZeneca, based in Cambridge, said it could not disclose further medical information.
“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” AstraZeneca said.
It …
-
Noosa News23 hours agoEnsure voices are heard – Proctor
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
General22 hours agoInflation hope as RBA decision leaves many disappointed